Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

SMALL-CAP WINNERS & LOSERS: Argo Blockchain plots US dual listing

Wed, 21st Jul 2021 11:04

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

----------

SMALL-CAP - WINNERS

----------

Argo Blockchain PLC, up 15% at 98.75 pence, 12-month range 3.51p-325p. The cryptocurrency mining firm says it has confidentially submitted a draft registration statement on form F-1 with the US Securities & Exchange Commission for a proposed dual listing and initial public offering of American depositary shares. The offering is expected to commence in the third quarter of 2021 after the SEC completes its review process.

----------

Norcros PLC, up 6.2% at 305.84p, 12-month range 135.49p-345p. The bathroom and kitchen products maker says revenue for 12 weeks to July 4 was more than double that reported for 2020, and up 19% on 2019. The UK business has continued to perform strongly, while the South African business has seen limited fallout from the recent period of social unrest. "A normalisation of consumer spending patterns and continued supply chain and Covid-19 disruption mean that market conditions are likely to remain uncertain. Notwithstanding, the board remains confident that the group will continue to win market share and make progress in line with its expectations for the current year," says Chief Executive Nick Kelsall.

----------

SMALL-CAP - LOSERS

----------

Nuformix, down 12% at 1.6p, 12-month range 1.53p-6.4p. Says that Chief Executive Anne Brindley has decided to step down. She has been made an "exceptional offer by another company which she wants to pursue". Brindley will remain in her position for the next six months.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
18 Jun 2024 18:37

IN BRIEF: Nuformix shares fall despite interim loss narrowing

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ended March 31...

17 Jun 2024 10:37

Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment

(Alliance News) - Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further protections for its...

12 Mar 2024 14:30

UK shareholder meetings calendar - next 7 days

1 Mar 2024 10:31

IN BRIEF: Nuformix announces subscription to raise GBP150,000

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross proceeds of GBP...

3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months th...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.